Marks Gilbert Lynn — SEC insider filings

SEC reporting owner CIK 1916940. 14 insider filings on record with FilingPulse; latest filed 2026-10-13.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2022-05-16 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
AN2 Therapeutics, Inc. (ANTX)Director14——19

Insider filings — Marks Gilbert Lynn

FiledFormIssuerReported transactionsSource
2026-10-134AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 2,283 @ $0EDGAR
2026-07-104AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 2,789 @ $0EDGAR
2026-04-104AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 3,775 @ $0EDGAR
2026-03-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 10,665 (derivative) · Disposition to issuer (D): 10,665 (derivative) · Grant/award (A): 10,362 (derivative) · Disposition to issuer (D): 10,362 (derivative) · Grant/award (A): 23,742 (derivative) · Disposition to issuer (D): 23,742 (derivative)EDGAR
2026-02-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 20,400 (derivative) @ $0EDGAR
2026-01-144AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 11,560 @ $0EDGAR
2025-10-144AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 10,367 @ $0EDGAR
2025-07-114AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 11,875 @ $0EDGAR
2025-05-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 19,111 (derivative) @ $0EDGAR
2025-04-114AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 9,705 @ $0EDGAR
2024-12-234AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 8,972 @ $0EDGAR
2024-06-214AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 64,503 (derivative) @ $0EDGAR
2023-06-094AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 23,742 (derivative) @ $0EDGAR
2022-05-164AN2 Therapeutics, Inc. (ANTX)Grant/award (A): 10,362 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1916940 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs